Indication
Smooth Muscle Dysfunction Syndrome
1 clinical trial
1 product
Clinical trial
Nicotinamide Riboside (NR) to Treat Moyamoya-like Cerebrovascular Disease in Smooth Muscle Dysfunction Syndrome (SMDS)Status: Recruiting, Estimated PCD: 2025-07-25
Product
Nicotinamide riboside